These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1751802)

  • 21. Hemolytic anemia secondary to interferon treatment for chronic B hepatitis.
    Fornaciari G; Bassi C; Beltrami M; Castagnetti E; Maccari S; Plancher AC
    J Clin Gastroenterol; 1991 Oct; 13(5):596-7. PubMed ID: 1744407
    [No Abstract]   [Full Text] [Related]  

  • 22. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
    N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Severe exacerbation of chronic hepatitis B following interferon therapy].
    Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
    Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between HLA class I antigens and response to interferon therapy in children with chronic HBV hepatitis.
    Giacchino R; Nocera A; Timitilli A; Cristina E; Giambartolomei G; Caocci F; Cirillo C; Barocci S
    Arch Virol Suppl; 1992; 4():281-3. PubMed ID: 1450702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
    Krogsgaard K; Bindslev N; Christensen E; Craxi A; Schlichting P; Schalm S; Carreno V; Trepo C; Gerken G; Thomas HC
    J Hepatol; 1994 Oct; 21(4):646-55. PubMed ID: 7814812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
    Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
    Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of chronic hepatitis B with interferon alfa-2b (Intron A)].
    Cianciara J; Laskus T; Hryniewicz H; Jabłońska J; Loch T
    Przegl Epidemiol; 1991; 45(4):315-20. PubMed ID: 1841409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of chronic hepatitis B and C.
    Dusheiko GM
    S Afr Med J; 1994 Aug; 84(8 Pt 2):563-70. PubMed ID: 7863401
    [No Abstract]   [Full Text] [Related]  

  • 31. [What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data?].
    Gerken G
    Internist (Berl); 1993 Nov; 34(11):1062-5. PubMed ID: 8282492
    [No Abstract]   [Full Text] [Related]  

  • 32. [The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis].
    Cervoni JP; Serfaty L; Picard O; Imbert JC; Poupon R
    Gastroenterol Clin Biol; 1995 Mar; 19(3):324-5. PubMed ID: 7781955
    [No Abstract]   [Full Text] [Related]  

  • 33. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.
    Günther S; Meisel H; Reip A; Miska S; Krüger DH; Will H
    Virology; 1992 Mar; 187(1):271-9. PubMed ID: 1736529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated course of interferon treatment in chronic hepatitis B in childhood.
    Giacchino R; Timitilli A; Cristina E; Giambartolomei G; Leonardi D; Caocci F; Cirillo C
    Arch Virol Suppl; 1992; 4():273-6. PubMed ID: 1450700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
    Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
    Cianciara J; Laskus T
    Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe exacerbation of chronic active hepatitis B during interferon alpha therapy.
    Laskus T; Radkowski M; Slusarczyk J; Cianciara J
    Digestion; 1992; 52(1):61-4. PubMed ID: 1426700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.